From Niche Diet to State Contract: The New Economics of Food as Medicine

GLEN COVE, NY – August 11, 2026 – An announcement that a New York-based meal delivery service landed on the Inc. 5000 list of fastest-growing companies might typically register as a minor business success story. But when the company in question is Epicured, and its 219% three-year revenue growth is fueled by state Medicaid contracts and partnerships to manage chronic disease, the story transcends the business pages. It becomes a critical signal of a fundamental rewiring of American healthcare.

Epicured’s ranking at No. 1595 is more than a validation of a business model; it’s a data point illustrating the maturation of a concept long relegated to the wellness fringe: “food is medicine.” For decades, the phrase has been an aspirational slogan. Today, it’s becoming a line item on healthcare budgets, driven by the unsustainable costs of chronic illness and a growing body of clinical evidence. The story of Epicured is a case study in how this shift is being operationalized, moving from theory to practice, from consumer choice to clinical prescription.

The Anatomy of a Systemic Shift

Founded in 2016, Epicured began by solving a highly specific problem for a historically underserved patient population: providing meals for the low FODMAP diet, a complex nutritional therapy for digestive conditions like IBS. This niche-first strategy provided a clinical foothold. A decade later, the company has evolved into a multi-therapeutic platform addressing diabetes, cardiovascular disease, and other conditions that plague the U.S. healthcare system.

This expansion mirrors the trajectory of the food-is-medicine sector itself, which is projected to grow into a market worth over $38 billion globally by 2034. The growth isn't speculative; it's a direct response to a healthcare crisis. With chronic diseases accounting for the vast majority of healthcare spending, payers and providers are desperately seeking more effective and cost-efficient interventions.

Epicured’s CEO and co-founder, Richard Bennett, frames the company’s recent Inc. 5000 recognition in this broader context. "Being named to the Inc. 5000 is an honor, but what it represents matters more than the recognition itself," he said in a statement. "We started this company because we saw firsthand how much the right nutrition can change someone's health... This growth is a reflection of our team's relentless focus on connecting food and health in ways that genuinely change people's lives."

This sentiment underscores a crucial point: the company’s growth isn't just about selling more meals. It's about successfully embedding nutrition into the formal structures of care delivery, a far more complex and significant achievement.

Weaving Nutrition into the Fabric of Healthcare

The most telling indicator of this structural shift lies in Epicured’s move beyond direct-to-consumer sales and into the world of commercial healthcare. The company is now a key provider within New York State's landmark $7.5 billion Section 1115 Medicaid Waiver, a program designed to address the social determinants of health for the state's most vulnerable populations.

Under this waiver, which officially launched in 2025, eligible Medicaid members can receive medically tailored meals, grocery boxes, and nutrition counseling—all paid for by the state. Epicured provides up to 21 fresh, chef-prepared meals per week, specifically designed by dietitians to manage conditions from diabetes to kidney disease. This isn’t a charity program; it’s a reimbursed healthcare service, built on the premise that providing the right food is cheaper and more effective than paying for emergency room visits and hospitalizations down the line.

Similarly, the company has partnered with Fallon Health to serve participants in Massachusetts’ Program of All-Inclusive Care for the Elderly (PACE). By delivering approximately 1,000 medically tailored meals per week, the partnership helps older adults with complex health needs manage their conditions at home, supporting their independence and reducing the need for more intensive, costly care settings.

These partnerships represent the holy grail for the food-is-medicine movement: payer integration. They transform food from a personal responsibility into a covered benefit, acknowledging that for many, access and affordability are insurmountable barriers to a healthy diet.

Building the Infrastructure for a Health Revolution

Executing this vision at scale requires more than just good recipes; it demands a sophisticated and robust operational backbone. Acknowledging that food which meets clinical needs often sacrifices quality and flavor, Epicured has built its model on a combination of culinary expertise, dietetics, and industrial logistics. The company’s recent launch of a new 30,000-square-foot production facility on Staten Island is a testament to this.

This facility is not merely an expanded kitchen. It is the engine that allows the company to meet the rigorous demands of its healthcare contracts, producing thousands of medically precise, high-quality meals. The planned expansion with a West Coast production facility signals a national ambition, aiming to create a network capable of serving partners and consumers across the country. This infrastructure build-out directly addresses one of the key challenges facing the food-is-medicine sector: scalability. It proves that it is possible to move from localized pilots to large-scale, consistent delivery.

A Multi-Front Approach to Nutrition

While partnerships with Medicaid and PACE are transforming public health, Epicured has diversified its approach, demonstrating the broad applicability of its core competency. Its expansion into performance nutrition, where it serves as a solutions partner to professional sports organizations, treats food as a tool for optimizing human potential at the highest level.

Simultaneously, its Life Sciences Division supports pharmaceutical research, providing specific diets required for clinical trials. This move cleverly positions the company as a critical partner in the development of new therapies, embedding nutrition into the very process of medical innovation.

Taken together, these initiatives paint a picture of a company strategically positioning nutrition as an indispensable component across the entire health and wellness spectrum—from managing chronic illness in vulnerable populations to enhancing the performance of elite athletes and enabling cutting-edge medical research. The story of Epicured’s growth is a powerful indicator that the long-overdue integration of nutrition into mainstream medicine is not only possible, but is already well underway.